Clorox (CLX) Receiving Somewhat Critical Media Coverage, Study Shows

News stories about Clorox (NYSE:CLX) have been trending somewhat negative on Tuesday, InfoTrie reports. The research group identifies negative and positive media coverage by monitoring more than six thousand news and blog sources in real time. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Clorox earned a media sentiment score of -1.00 on their scale. InfoTrie also gave media coverage about the company an news buzz score of 10 out of 10, indicating that recent media coverage is extremely likely to have an effect on the stock’s share price in the next few days.

Here are some of the news stories that may have effected Clorox’s analysis:

A number of analysts have issued reports on the company. Wells Fargo & Co reaffirmed a “hold” rating and issued a $157.00 price objective on shares of Clorox in a research note on Monday. Zacks Investment Research raised Clorox from a “sell” rating to a “hold” rating in a research note on Monday, January 7th. Morgan Stanley set a $142.00 price objective on Clorox and gave the stock a “sell” rating in a research note on Thursday, December 20th. Bank of America reaffirmed a “neutral” rating and issued a $170.00 price objective (up previously from $150.00) on shares of Clorox in a research note on Thursday, December 6th. Finally, Citigroup lifted their price objective on Clorox from $153.00 to $169.00 and gave the stock a “hold” rating in a research note on Tuesday, November 20th. Four investment analysts have rated the stock with a sell rating, seven have given a hold rating and three have assigned a buy rating to the company’s stock. The stock has an average rating of “Hold” and an average price target of $147.85.

NYSE CLX opened at $158.38 on Tuesday. The company has a market cap of $19.13 billion, a PE ratio of 25.30, a P/E/G ratio of 3.74 and a beta of 0.29. The company has a debt-to-equity ratio of 3.38, a quick ratio of 0.65 and a current ratio of 1.07. Clorox has a fifty-two week low of $113.57 and a fifty-two week high of $167.70.

Clorox (NYSE:CLX) last released its earnings results on Monday, February 4th. The company reported $1.40 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $1.30 by $0.10. The firm had revenue of $1.47 billion for the quarter, compared to the consensus estimate of $1.47 billion. Clorox had a return on equity of 102.65% and a net margin of 13.59%. The company’s revenue for the quarter was up 4.0% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.77 EPS. On average, equities analysts expect that Clorox will post 6.32 earnings per share for the current year.

The business also recently announced a quarterly dividend, which will be paid on Friday, February 8th. Stockholders of record on Wednesday, January 23rd will be given a dividend of $0.96 per share. This represents a $3.84 annualized dividend and a dividend yield of 2.42%. The ex-dividend date of this dividend is Tuesday, January 22nd. Clorox’s dividend payout ratio is currently 61.34%.

In other news, CAO Jeff Baker sold 3,694 shares of the business’s stock in a transaction that occurred on Friday, December 7th. The stock was sold at an average price of $162.56, for a total transaction of $600,496.64. Following the transaction, the chief accounting officer now owns 5,743 shares of the company’s stock, valued at approximately $933,582.08. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, CEO Benno O. Dorer sold 152,449 shares of the business’s stock in a transaction that occurred on Tuesday, December 4th. The shares were sold at an average price of $164.83, for a total value of $25,128,168.67. Following the transaction, the chief executive officer now directly owns 111,735 shares in the company, valued at approximately $18,417,280.05. The disclosure for this sale can be found here. In the last three months, insiders have sold 246,143 shares of company stock worth $40,344,398. Corporate insiders own 1.40% of the company’s stock.

TRADEMARK VIOLATION WARNING: “Clorox (CLX) Receiving Somewhat Critical Media Coverage, Study Shows” was first reported by Dakota Financial News and is the sole property of of Dakota Financial News. If you are viewing this piece on another domain, it was copied illegally and reposted in violation of international copyright & trademark laws. The legal version of this piece can be accessed at

Clorox Company Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Cleaning, Household, Lifestyle, and International. The company offers laundry additives, including bleach products under the Clorox brand, as well as Clorox 2 stain fighter and color booster; home care products primarily under the Clorox, Formula 409, Liquid-Plumr, Pine-Sol, S.O.S, and Tilex brands; naturally derived products under the Green Works brand; and professional cleaning, disinfecting, and food service products under the Clorox, Dispatch, HealthLink, Clorox Healthcare, Hidden Valley, KC Masterpiece, and Soy Vay brands.

Read More: Buyback

Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with's FREE daily email newsletter.

Leave a Reply